Furthermore, UCHL1 methylation was positively associated with worse overall survival rates, which is consistent with former studies in breast cancer [33], esophageal squamous cell carcinoma [32], and renal cell carcinoma [34]. This evidence concerns the gene UCHL1 and breast carcinoma.